,,ii #aahth ,,congress #ast ,session ,s4 #bcbi ,,in ,,the ,,senate ,,of ,,the ,,united ,,states ,july #ac1 #bjbc,mr4 ,hickenlooper 7for himself and ,mr4 ,budd7 introduced the following bill2 which was read twice and referred to the ,committee on ,health1 ,education1 ,labor1 and ,pensions ,a ,,bill ,to establish an emerging pathogen preparedness program within the ,food and ,drug ,administration to improve regulatory oversight of medical countermeasures for future pandemics4 #a4 ,short title ,this ,act may be cited as the ,emerging ,pathogen ,preparedness ,program ,authorization ,act4 #b4 ,emerging pathogens preparedness program 7a7 ,in general ,section #efe of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cfj;bbb-#d7 is amended by adding at the end the following3 7j7 ,emerging pathogens preparedness program 7#a7 ,in general ,the ,secretary shall establish a program to facilitate the development1 review1 licensure1 approval1 and clearance of countermeasures1 and products that could potentially be countermeasures1 under the jurisdiction of the ,center for ,biologics ,evaluation and ,research4 7#b7 ,activities ,the activities of the program established under paragraph 7#a7 may include1 either directly or by grant1 contract1 or cooperative agreement1 the following3 7,a7 ,any activities described in subsection 7b74 7,b7 ,activities to advance scientific research related to the development of tools1 standards1 and approaches to assess the safety1 efficacy1 quality1 and performance of countermeasures4 7,c7 ,activities to maintain or enhance surveillance programs that monitor countermeasures4 7,d7 ,activities to help ensure blood safety and availability4 7,e7 ,prioritizing the research and development of platform vaccine technologies to support an emergency use authorization request under section #efd or an application under #cea7;a7 of the ,public ,health ,service ,act4 7,f7 ,such other activities as the ,secretary determines necessary or appropriate4 7#c7 ,rule of construction ,nothing in this subsection shall be construed to alter the authority of the ,secretary to license1 approve1 clear1 or authorize countermeasures1 including biological products1 pursuant to section #cea of the ,public ,health ,service ,act or section #eje or #efd of this ,act1 including standards of evidence and applicable conditions for licensure1 approval1 clearance1 or authorization4 4 7b7 ,authorization of appropriations ,to carry out subsection 7j7 of section #efe of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cfj;bbb-#d71 as added by subsection 7a71 there is authorized to be appropriated #fj1jjj1jjj for each of fiscal years #bjbd through #bjbh4